2
Total investments
1
Early stage
1
Mid stage
0
Late stage
8y
Years active
Portfolio
2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Feb 2021
Wave Neuroscience is the leading innovator in biomarker-guided brain health technologies.
Investor
Nov 2018
Cybraics revolutionizes cybersecurity threat detection and response with nLighten™, the world’s leading autonomous SIEM and MDR platform. Developed out of an award-winning AI and machine learning research program with the U.S. Department of Defense, nLighten uses more than 250 advanced behavioral analytics to filter scattered, siloed data and:
· Dramatically reduce false positives
· Catch unknown threats other tools miss
· Automatically create actionable cases
Cybraics software integrates seamlessly with your existing security stack to deliver a proven, high-ROI solution, and our expert SOC team is here to support you 24/7/365.
Experience · 3 entries
All (3)
Investments (2)
2023
Managing Partner
Mar 2023
Cut IT costs with our streamlined procurement process. Real-time analysis of costs, risks, and performance, along with competitive bidding, means youll never overspend on IT again.
2021
Investor
Feb 2021
Wave Neuroscience is the leading innovator in biomarker-guided brain health technologies.
2018
Investor
Nov 2018
Cybraics revolutionizes cybersecurity threat detection and response with nLighten™, the world’s leading autonomous SIEM and MDR platform. Developed out of an award-winning AI and machine learning research program with the U.S. Department of Defense, nLighten uses more than 250 advanced behavioral analytics to filter scattered, siloed data and:
· Dramatically reduce false positives
· Catch unknown threats other tools miss
· Automatically create actionable cases
Cybraics software integrates seamlessly with your existing security stack to deliver a proven, high-ROI solution, and our expert SOC team is here to support you 24/7/365.